Clinical Trial Update: Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of BCD-180 in Patients With Axial Spondyloarthritis (LEVENTA) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for BCD-180 in axial spondyloarthritis, currently active but not recruiting, assessing efficacy, safety, pharmacokinetics and phar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axial Spondyloarthritis

Drugs mentioned

• BCD-180

Snippet

Sponsor: Biocad | Conditions: Axial Spondyloarthritis | Phase 3 | Status: ACTIVE_NOT_RECRUITING